Design and Analysis of Bioavailability and Bioequivalence Studies Design and Analysis of Bioavailability and Bioequivalence Studies
Chapman & Hall/CRC Biostatistics Series

Design and Analysis of Bioavailability and Bioequivalence Studies

    • $59.99
    • $59.99

Publisher Description

Preeminent Experts Update a Well-Respected BookTaking into account the regulatory and scientific developments that have occurred since the second edition, Design and Analysis of Bioavailability and Bioequivalence Studies, Third Edition provides a complete presentation of the latest progress of activities and results in bioavailability and bioequiva

GENRE
Science & Nature
RELEASED
2008
October 15
LANGUAGE
EN
English
LENGTH
760
Pages
PUBLISHER
CRC Press
SELLER
Taylor & Francis Group
SIZE
11
MB
Innovative Methods for Rare Disease Drug Development Innovative Methods for Rare Disease Drug Development
2020
Design and Analysis of Clinical Trials Design and Analysis of Clinical Trials
2013
Biosimilars Biosimilars
2013
Design and Analysis of Animal Studies in Pharmaceutical Development Design and Analysis of Animal Studies in Pharmaceutical Development
1998
Controversial Statistical Issues in Clinical Trials Controversial Statistical Issues in Clinical Trials
2016
Encyclopedia of Biopharmaceutical Statistics - Four Volume Set Encyclopedia of Biopharmaceutical Statistics - Four Volume Set
2018
Real-World Evidence in Drug Development and Evaluation Real-World Evidence in Drug Development and Evaluation
2021
Medical Risk Prediction Models Medical Risk Prediction Models
2021
Biomarker Analysis in Clinical Trials with R Biomarker Analysis in Clinical Trials with R
2020
Biosimilar Clinical Development: Scientific Considerations and New Methodologies Biosimilar Clinical Development: Scientific Considerations and New Methodologies
2016
Innovative Methods for Rare Disease Drug Development Innovative Methods for Rare Disease Drug Development
2020
Statistical Design, Monitoring, and Analysis of Clinical Trials Statistical Design, Monitoring, and Analysis of Clinical Trials
2021